Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      FDA approves first treatment for rare form of skin cancer

      FDA approves first treatment for rare form of skin cancer

      supriya kashyap kashyap25 March 2017 10:24 AM IST
      The U.S. Food and Drug Administration granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years...
      Sanofi, Regeneron sue Amgen to protect eczema drug from patent claims

      Sanofi, Regeneron sue Amgen to protect eczema drug from patent claims

      supriya kashyap kashyap25 March 2017 10:08 AM IST
      Boston : Sanofi SA and Regeneron Pharmaceuticals Inc filed a lawsuit seeking a court order declaring that their eczema drug Dupixent, awaiting a U.S....
      Mylan Receives Tentative Approval for TLE400 Under PEPFAR

      Mylan Receives Tentative Approval for TLE400 Under PEPFAR

      supriya kashyap kashyap24 March 2017 10:11 AM IST
      England : Mylan N.V., a leading global pharmaceutical company, announced receipt of tentative approval from the U.S. Food and Drug Administration...
      Hyderabad varsity inks MoU with Natco Pharma for research

      Hyderabad varsity inks MoU with Natco Pharma for research

      supriya kashyap kashyap24 March 2017 10:09 AM IST
      Hyderabad : University of Hyderabad (UoH) has signed an MoU with Natco Pharma for carrying out advance research in the areas of discovery of novel...
      Merck must face renewed Fosamax warning claims: US appeals court

      Merck must face renewed Fosamax warning claims: US appeals court

      supriya kashyap kashyap24 March 2017 9:13 AM IST
      A federal appeals court revived claims by several hundred plaintiffs who accused Merck & Co of failing to adequately warn about the risks of thigh...
      Apollo Group’s Preetha Reddy admits to lapses in healthcare delivery

      Apollo Group’s Preetha Reddy admits to lapses in healthcare delivery

      supriya kashyap kashyap23 March 2017 11:18 AM IST
      Kolkata : At a time when Apollo Gleneagles Hospital in the city is under the scanner for alleged medical negligence and malpractices, Apollo Group's...
      Novartis heart drug serelaxin fails late stage trial

      Novartis heart drug serelaxin fails late stage trial

      supriya kashyap kashyap23 March 2017 11:18 AM IST
      Novartis's heart failure drug serelaxin flopped in a late-stage trial by not cutting cardiovascular death or slowing disease progression, marking the...
      USA bans Indian drugmaker Divi

      USA bans Indian drugmaker Divi's factory

      supriya kashyap kashyap23 March 2017 11:17 AM IST
      US health regulators have banned a drug production site in India belonging to Divi's Laboratories Ltd due to manufacturing violations, sending the...
      GSK and Regeneron to mine gene data from 500,000 Britons

      GSK and Regeneron to mine gene data from 500,000 Britons

      supriya kashyap kashyap23 March 2017 11:13 AM IST
      Britain's GlaxoSmithKline and U.S.-based Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank, the world's most detailed...
      Mylan recalls 81,000 EpiPens outside US after reports of failure

      Mylan recalls 81,000 EpiPens outside US after reports of failure

      supriya kashyap kashyap23 March 2017 11:13 AM IST
      Generic drug maker Mylan NV has recalled about 81,000 EpiPen devices in countries outside the United States, following two reports of the life saving...
      Wockhardt gets USFDA nod for generic anti-bacterial drug

      Wockhardt gets USFDA nod for generic anti-bacterial drug

      supriya kashyap kashyap22 March 2017 11:19 AM IST
      New Delhi : Drug firm Wockhardt has received approval from the US health regulator to market generic version of Wyeth's Zosyn, used for treating...
      USFDA issues import alert on Divis Lab Vizag unit

      USFDA issues import alert on Divi's Lab Vizag unit

      supriya kashyap kashyap22 March 2017 11:14 AM IST
      New Delhi : Drug firm Divi's Laboratories said the US health regulator has issued an import alert on the products manufactured at one of its units in...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok